Pheton Holdings Ltd Class A Ordinary Shares Total Liabilities

Latest as of September 2025: $382.60K USD

Pheton Holdings Ltd Class A Ordinary Shares total liabilities. Based on the latest financial reports, Pheton Holdings Ltd Class A Ordinary Shares (PTHL) has total liabilities worth $382.60K USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PTHL asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Pheton Holdings Ltd Class A Ordinary Shares (2021–2024)

Total liabilities of Pheton Holdings Ltd Class A Ordinary Shares from 2021 to 2024. This chart illustrates how Pheton Holdings Ltd Class A Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data.

Pheton Holdings Ltd Class A Ordinary Shares Competitors by Total Liabilities

The table below lists competitors of Pheton Holdings Ltd Class A Ordinary Shares ranked by their total liabilities.

Company Country Total Liabilities
Danasupra Erapacific Tbk
JK:DEFI
Indonesia Rp2.69 Billion
Mec Resources Ltd
AU:MMR
Australia AU$437.22K
Pomvom
TA:PMVM
Israel ILA37.92 Million
Great Atlantic Resources Corp
V:GR
Canada CA$6.56 Million
Mid Wynd International Investment Trust plc
LSE:MWY
UK GBX1.90 Million
IBKS No3 SPAC
KQ:225430
Korea ₩21.04 Billion
Constellation Technologies Ltd
AU:CT1
Australia AU$793.97K

Liability Composition Analysis (2021–2024)

This chart breaks down Pheton Holdings Ltd Class A Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Pheton Holdings Ltd Class A Ordinary Sha assets under control.

Liquidity & Leverage Metrics

Pheton Holdings Ltd Class A Ordinary Shares Total Liabilities Ratios Explained

Pheton Holdings Ltd Class A Ordinary Shares total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 11.69 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.07 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pheton Holdings Ltd Class A Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pheton Holdings Ltd Class A Ordinary Shares (2021–2024)

The table below shows the annual total liabilities of Pheton Holdings Ltd Class A Ordinary Shares from 2021 to 2024.

Year Total Liabilities Change
2024-12-31 $538.55K -58.90%
2023-12-31 $1.31 Million +55.00%
2022-12-31 $845.41K +124.46%
2021-12-31 $376.65K --

About Pheton Holdings Ltd Class A Ordinary Shares

NASDAQ:PTHL USA Medical Devices
Market Cap
$2.64 Million
Market Cap Rank
#29658 Global
#6059 in USA
Share Price
$0.28
Change (1 day)
-5.73%
52-Week Range
$0.28 - $0.90
All Time High
$30.96
About

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment pl… Read more